Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments

The pharmacological treatment of cognitive impairments associated with schizophrenia is still a major unmet clinical need. Indeed, treatments with available antipsychotics generate highly variable cognitive responses among patients with schizophrenia. This has led to the general assumption that anti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Torrisi, Sebastiano Alfio, Laudani, Samuele, Contarini, Gabriella, De Luca, Angelina, Geraci, Federica, Managò, Francesca, Papaleo, Francesco, Salomone, Salvatore, Drago, Filippo, Leggio, Gian Marco
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694365/
https://ncbi.nlm.nih.gov/pubmed/33167370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13110365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados